Frontiers in Pharmacology | Neuropharmacology

Brief Research Report

Published on 08 Aug 2025

Fenofibrate treatment during withdrawal reverses symptoms of ethanol-induced depression in male rats

in Neuropharmacology

Marcelo León
Camila Vásquez-Ulloa
Lucas Marambio-Ruiz
Diliana Pérez-Reytor
Eduardo Karahanian

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1626031

292 views

Correction

Published on 07 Aug 2025

Correction: Harnessing nanotechnology for stem-cell therapies: revolutionizing neurodegenerative disorder treatments – a state-of-the-art update

in Neuropharmacology

Neevashini Chengebroyen
Anmol Seelan
Kamal Yoonus Thajudeen
Saad Ali Alshehri
Aritra Biswas
Israrahmed Adur
Vino Sundararajan
Sajitha Lulu Sudhakaran
Harpreet Singh

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1674993

443 views

Original Research

Accepted on 06 Aug 2025

Zebrafish-based assessment of luteolin's potential in modulating seizure responses

in Neuropharmacology

Sabrina Ester Schneider
Jefferson Pedroso
Cássia Alves Lima-Rezende
Samara Cristina Mazon
Aline E Dos Santos
Pablo S Gean
Marcelo Lanza
Mariana Appel Hort
J Vladimir Oliveira
Angelo Piato

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1656301

Original Research

Published on 06 Aug 2025

DMH1-loaded peptide nanomicelles restore myelin and attenuate neuroinflammation in trigeminal neuralgia via CCL5 suppression

in Neuropharmacology

Shuangyin Xia
Xiunan Qin
Yaping Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1590624

1,858 views

Review

Accepted on 05 Aug 2025

Pharmacological mechanism of natural antidepressants: The role of Epigenetic Modifications

in Neuropharmacology

Yitong Lu
Ruirui Shang
Xia Zhong
Jingbo Shi
Guangheng Zhang
Weijie Zhao
Jing Teng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1616322

107 views

Original Research

Published on 05 Aug 2025

Ineffectiveness of tirzepatide in mitigating Doxorubicin-induced oxidative stress and cognitive deficits in a rat model

in Neuropharmacology

Salma A. Alolayan
Ahmad H. Alhowail

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1638527

287 views

Original Research

Accepted on 01 Aug 2025

Polydatin ameliorates hyperhidrosis by targeting Aqp5 in a mouse model

in Neuropharmacology

Jian-Feng Chen
Zhi Feng
Feng-Qiang Yu
Rui-Qin Qiu
Li Xu
Jian-Bo Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1589143

173 views

Original Research

Published on 01 Aug 2025

Neurological adverse events associated with antidepressants: a comprehensive 22-year analysis of the FDA adverse event reporting system

in Neuropharmacology

Qian Yu
Jingyang Yao
Enping Li
Mingkai Xia
Ziang Hu
Yun Xiao
Jianliang Huang
Mingsheng Lei

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1644241

971 views

Review

Published on 01 Aug 2025

Dexmedetomidine and the glymphatic system: a new perspective in managing postoperative cognitive dysfunction

in Neuropharmacology

Sha-Sha Zhang
Fan-Geng Meng
Yuan-Yuan Rong
Yi-Wen Zhang
Hua-Qin Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1648308

428 views

Review

Accepted on 31 Jul 2025

From a Traditional Medicine Monomer to a Modern Neurotherapeutic Scaffold: A Review of SAR-Driven Tetramethylpyrazine Derivatives for Cerebrovascular and Cognitive Health

in Neuropharmacology

Xiaodi Wang
Muhan Cao
Yi Xu
Xifei Yang
Qinghua Hou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1653056

124 views

Original Research

Published on 31 Jul 2025

α-Lipoic acid mitigates age-related macular degeneration via ferroptosis: integrative multi-omics and network pharmacology

in Neuropharmacology

Yaqiong Zhang
Yuanyuan Chen
Chenglin Sun
Fang Li
Yin Shen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1626907

496 views

Original Research

Accepted on 30 Jul 2025

Escalated oxycodone self-administration is associated with expression of voltage gated and calcium activated potassium channels in the mesocorticolimbic system in rats

in Neuropharmacology

Ammanuel Y. Wabreha
Nasser Adjei
Bruce Neil Ladenheim
Jean Lud Cadet
Atul P Daiwile

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1653356

286 views

Original Research

Accepted on 30 Jul 2025

Systems Pharmacology Identifies Ajugol-mediated NF-κB/Caspase-3 Inhibition and Isoacteoside-Driven p62/mTOR-mediated Autophagy as Key Mechanisms of Rehmanniae Radix and Its Processed Form in Alzheimer’s Treatment

in Neuropharmacology

Xiang Han
Xianglong Meng
Yuhui Wu
Xia Wei
Simin Xue
Xiaoqin Liu
Chenzi Lyu
Ziang Li
Xiaoning Yan
Hyo Won Jung

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1644847

154 views

Original Research

Published on 30 Jul 2025

Identification of potential drug-induced neuralgia signals through disproportionality analysis of the FAERS database

in Neuropharmacology

Yating An
Ying Zheng
Ziwei Jiang
Meng Meng
Jintuo Yin
Yahui An

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1645114

320 views

Case Report

Accepted on 29 Jul 2025

Syndrome of inappropriate antidiuretic hormone secretion induced by pramipexole: a case report and literature review

in Neuropharmacology

Ke Qian Chen
Xiang Liu
Hai-Bo Lei

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1627245

Review

Accepted on 29 Jul 2025

Advancing Prevention and Treatment Strategies for Drug-Induced Hearing Loss

in Neuropharmacology

Tony Bonilla
Jake DiFatta
Esperanza Bas Infante
Stefania Goncalves

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1620679

156 views